cells prone to form tumorigenesis, resemble normal stem cells with self-renewal and differentiation characteristics. CSCs have recently been identified in leukemia and various types of solid tumors. There is growing evidence indicating that CSCs might be the principal cause for the development of resistance to cancer treatments, recurrence, and metastasis. Emerging data indicates that CSCs and normal stem cells may share cellular pathways regulating proliferation and differentiation. These pathways include, but not limited to, polycomb group transcriptional repressor Bmi-1, Notch, Sonic hedgehog, and Wnt pathways. Therefore, identification of CSC markers, selection and development of unique therapeutics targeting CSCs and related signaling pathways have been extensively investigated. In this special issue, we publish articles that explore aspects of complementary and alternative medicine (CAM) associated with CSCs in basic research, in translational medicine, and in clinical application for cancer treatment. The topic will highlight current research, encourage additional research, draw attention to the subject, and ultimately help advance the field of CAM application in CSCs.
Considering The aforementioned papers published in this special issue represent quite attractive and promising results about CAM in management of CSCs. In most of these papers, the mechanisms underlying their anti-CSCs properties have been well addressed.
